Inhalation Technologies - A Breath of Fresh Air
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 73 (Table of Contents)
Published: 1 Jul-2006
DOI: 10.3833/pdr.v2006.i73.488 ISSN: 1756-7874
Section: Features
Fulltext:
Abstract
The approval of Exubera#174; (inhaled PEGylated insulin) for the treatment of diabetes highlights the vogue for and potential for commercial success in reformulating existing therapies for pulmonary delivery...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS